1. South Korea Stocks

  2. •

    Consumer Defensive

  3. •

    Household & Personal Products
CHA AI Healthkare

CHA AI Healthkare

025620.KS
CHA AI HealthkareKR flagKorea Exchange
6,760.00
KRW
-210.00
- -
54.22BMarket Cap
CHA AI Healthkare
025620.KS
(Korea Exchange)

Recent

price

6,760.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
3,920,565.02
3,230,923.54
9,826,974.73
1,138,916.55
3,248.87
42,352.42
83,653.88
76,329.95
72,931.06
28,576.28
10,814.24
5,101.37
2,211.24
3,695.1
3,503.89
- -
710.06
Revenue per Share
-329,972.46
-559,689.96
-1,113,731.24
-630,429.69
-3,931.56
-81,920.49
12,578.48
16,121.69
-682.67
-45,840.62
-7,712.73
-13,134.86
-7,588.09
-1,561
-2,122
- -
-86.47
Basic EPS, GAAP
-188,284.11
-44,182.98
-565,527.03
-62,913.15
-2,452.42
-87,119.31
-5,881.05
-35,902.79
-22,369.42
1,510.23
-1,931.97
-3,264.88
-4,590.56
-2,355.74
-1,599.92
- -
-569.54
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
369,583.66
478,956.34
1,796,899.7
-157,814.62
5,868.54
-83,717.29
16,533.82
30,446.83
28,140.55
-17,626.84
-17,702.82
-23,762.5
-44,634.58
-30,444.94
-31,753.44
- -
-13,124.77
Book Value per Share
959,222.58
447,448.56
2,515,152.06
127,294.75
9,126.16
61,742.87
79,651.59
70,215.93
65,753.51
28,490.63
18,189.88
18,011.52
14,663.39
9,108.97
6,582.09
- -
6,631.39
Tangible Book Value per Share
- -
- -
- -
- -
2
- -
1
2
2
2
3
3
3
4
4
- -
11
Basic Weighted Avg Shares
70,033
57,607
50,422
30,095
7,149
8,011
83,424
129,713
132,015
52,619
30,519
14,978
6,246
16,089
15,675
7,305
7,491
Sales/Revenue/Turnover
-5.79
-14.38
-9.94
-42.57
-282.08
-134.06
15.99
17.19
5.41
-98.85
-37.14
-97.55
-127.76
-56.39
-30.95
-97.25
-97.51
Operating Margin (%)
1,414
1,143
1,216
1,124
1,602
681
265
846
1,871
3,885
1,610
1,743
952
560
567
755
803
Depreciation Expense
-5,894
-9,979
-5,715
-16,658
-8,651
-15,496
12,544
27,397
-1,236
-84,408
-21,766
-38,564
-21,435
-6,797
-9,493
1,367
-912
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
533.28
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-8.42
-17.32
-11.33
-55.35
-121.01
-193.43
15.04
21.12
-0.94
-160.41
-71.32
-257.48
-343.16
-42.25
-60.56
18.71
-12.18
Profit Margin (%)
-6,330
-18,735
-14,390
-22,918
-5,397
11,299
58,406
59,393
95,839
-13,320
-8,950
7,598
15,917
10,391
3,826
16,598
7,839
Working Capital
4,104
- -
2,800
6,600
- -
3,296
- -
8,000
35,782
2,008
1,082
469
387
174
369
668
337
LT Debt
17,276
8,079
12,969
3,387
20,085
13,049
86,419
126,998
126,633
53,253
59,827
60,136
41,581
39,987
29,636
75,427
70,710
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
-18.46
- -
- -
- -
- -
- -
- -
-10.22
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
-7.61
- -
- -
- -
- -
- -
- -
-2.04
3.91
Return on Capital (%)
-61.73
-131.81
-64.35
- -
- -
- -
- -
80.31
-2.41
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
4,781
29,897
28,323
LT Borrowings
- -
- -
- -
LT Finance Leases
285
668
337
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
8
18
18
Market Capitalization
69,989
63,713
94,953

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
19,927
50,751
44,954
Cash, Cash Equivalents & STI
9,217
42,040
35,497
Accounts Receivable, Net
1,381
1,226
862
Inventories
3,304
2,974
3,164
Total Current Liabilities
10,518
34,153
37,115
Payables & Accruals
- -
- -
- -
ST Debt
4,781
29,897
28,323
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
65.78%
18.89%
154.51%
Free Cash Flow
50.14%
12.42%
2.15%
Net Income, GAAP
637.91%
-22.05%
-114.4%
Sales/Revenue/Turnover
88.88%
-1.52%
-53.4%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
5,318
5,160
2,701
2,496
15,675
2025
1,751
1,965
1,626
1,963
7,305
2026
1,937
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-93
-255
-933
- -
-2,122
2025
-528
247.17
-271.54
- -
- -
2026
-255.14
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
China In-Tech Limited (0464.HK)
PayChest, Inc. (PYCT)
Acquired Sales Corp. (AQSP)
L'Oréal S.A. (OR.PA)
Intercos S.p.A. (ICOS.MI)
Bajaj Consumer Care Limited (BAJAJCON.NS)
Business
Jayjun Cosmetic Co., Ltd. manufactures and distributes cosmetic products primarily in South Korea. The company offers facial care products including mask packs such as black water glow masks and intensive shining masks, eye gel patches like green tea and roselle tea variants, skincare items comprising toners, mists, pads, ampoules, serums, essences, lotions, emulsions, creams, gels, cleansing and peeling solutions, sun care, and beauty accessories; makeup products; collagen jelly and related items; as well as specialized lines for skin cell texture improvement, moisture and moisturizing, whitening and brightening, sensitive and calming care, nutritional elasticity, anti-aging, trouble care, and UV protection. It operates through three segments: Cosmetics, Entertainment and Advertising encompassing record and music businesses, performances, management services, and advertising agencies, and Medical Devices. Founded in 1972 and headquartered in Seoul, South Korea, the company conducts geographic operations in South Korea, China, and the United States. Recent developments include receiving KRW 2.5 billion in funding from NS ENM Co., Ltd. in 2024 and expecting KRW 40 billion in additional funding as announced in March 2025, alongside issuances of convertible bonds and rights offerings in 2025, a CEO change to Byung-Cheol Koh in 2023, and full-year 2024 earnings reported in March 2025.